Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Depreciation & Amortization (CF): 2010-2025

Historic Depreciation & Amortization (CF) for Alkermes (ALKS) over the last 15 years, with Sep 2025 value amounting to $8.1 million.

  • Alkermes' Depreciation & Amortization (CF) rose 15.89% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.2 million, marking a year-over-year decrease of 25.01%. This contributed to the annual value of $28.5 million for FY2024, which is 61.92% down from last year.
  • According to the latest figures from Q3 2025, Alkermes' Depreciation & Amortization (CF) is $8.1 million, which was up 3.35% from $7.8 million recorded in Q2 2025.
  • Alkermes' 5-year Depreciation & Amortization (CF) high stood at $21.1 million for Q4 2021, and its period low was $6.7 million during Q2 2024.
  • For the 3-year period, Alkermes' Depreciation & Amortization (CF) averaged around $11.5 million, with its median value being $8.1 million (2024).
  • Per our database at Business Quant, Alkermes' Depreciation & Amortization (CF) slumped by 64.98% in 2024 and then climbed by 17.42% in 2025.
  • Over the past 5 years, Alkermes' Depreciation & Amortization (CF) (Quarterly) stood at $21.1 million in 2021, then declined by 6.93% to $19.7 million in 2022, then declined by 5.77% to $18.5 million in 2023, then crashed by 63.07% to $6.8 million in 2024, then climbed by 15.89% to $8.1 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $8.1 million for Q3 2025, versus $7.8 million for Q2 2025 and $7.4 million for Q1 2025.